NYSEMKT: IBOImpact Biomedical Inc Stock Ownership - Who owns Impact Biomedical?
Insider buying vs selling
Have Impact Biomedical Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jason Grady | Director | 2026-03-23 | 50,000 | $0.65 | $32.50kSell |
| Dss Inc | 10% Owner | 2025-05-27 | 45,400 | $0.54 | $24.52kSell |
| Dss Inc | 10% Owner | 2025-05-27 | 45,400 | $0.54 | $24.52kSell |
| Dss Inc | 10% Owner | 2025-05-22 | 115,600 | $0.55 | $63.46kSell |
| Dss Inc | 10% Owner | 2025-05-22 | 115,600 | $0.55 | $63.46kSell |
| Heng Fai Ambrose Chan | Director | 2025-04-04 | 180,000 | $0.96 | $172.80kSell |
| Dss Inc | 10% Owner | 2025-04-04 | 890,800 | $0.95 | $845.37kSell |
| Heng Fai Ambrose Chan | Director | 2025-04-03 | 351,631 | $0.58 | $203.59kSell |
| Heng Fai Ambrose Chan | Director | 2025-04-03 | 351,555 | $0.50 | $174.02kSell |
| Heng Fai Ambrose Chan | Director | 2025-04-03 | 273,286 | $0.78 | $212.89kSell |
IBO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IBO insiders and whales buy or sell their stock.
IBO Shareholders
What type of owners hold Impact Biomedical Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Dss Inc | 2.37% | 2,556,906 | $1.47M | Insider |
| Vanguard Group Inc | 0.76% | 814,885 | $468.56k | Institution |
| Blackrock Inc | 0.24% | 259,946 | $149.47k | Institution |
| Jason Grady | 0.23% | 250,182 | $143.85k | Insider |
| Millennium Management LLC | 0.13% | 137,823 | $79.25k | Institution |
| Frank D. Heuszel | 0.09% | 97,344 | $55.97k | Insider |
| Geode Capital Management LLC | 0.07% | 74,378 | $42.77k | Institution |
| Two Sigma Investments LP | 0.04% | 39,827 | $22.90k | Institution |
| Two Sigma Securities LLC | 0.02% | 22,695 | $13.05k | Institution |
| Susquehanna International Group LLP | 0.02% | 16,501 | $9.49k | Institution |
IBO vs Biotech Stocks
Impact Biomedical Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.